We compared the methylation status between patients from Taiwan and Western countries while using the human Methylation 450K BeadChip array, which showed that Taiwanese breast cancer patients had generally higher methylation levels in the CCND2 promoter and exon 1 regions than patients from western countries in the TCGA dataset. The gene discussed is CCND2; the disease is breast cancer.